Track the 泰恩康 stock price and the full insider trade history of the company, a listed equity based in China. Shares are listed on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 泰恩康 has logged 13 public disclosures. Market capitalisation: €12.3bn. The latest transaction was reported on 6 June 2024 (Purchase). Among the most active insiders: 李挺. All data is accessible without an account.
13
Insider Decl.
0
Thresholds
·
13 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 18,214 of 25,564 companies
37.6
score / 100
Value
33
Quality
42
FCF yld-1.1%
Earn yld0.3%
EV/EBITDA·
ROE0.4%
Gross mgn54%
Net mgn4.2%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.